Impact of a Structured Clinical Assessment MIDSA, Its Feedback and Support for Change on Commitment to Care of Perpetrators of Sexual Offenses
NCT ID: NCT05013996
Last Updated: 2025-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
10 participants
INTERVENTIONAL
2022-01-20
2025-01-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tertiary Prevention of Child Sexual Abuse
NCT06126926
Collaborative Nursing Care-based Intervention in Mental Health Day Hospital Users
NCT04814576
Evaluation of the Impact of Participation in a Psycho-education Program for Victims of Sexual Violence
NCT06718387
Novel Methods for Implementing Measurement-Based Care for Youth in Low-resource Environments
NCT05644756
Effects of a Standardized Post-coercion Review Session.
NCT03512925
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Patients randomized to the experimental (MIDSA groupe) will be treated according to the usual methods of each of the centers (CMP / CRIAVS / private practitioners, etc.) completed with the Multidimensional Inventory of Development, Sex, and Aggression-MIDSA groupe Multidimensional Inventory of Development, Sex, and Aggression-inventory tool.
MIDSA
Multidimensional Inventory of Development, Sex, and Aggression
Control
Patients randomized to the control group will be treated according to the usual methods of each of the participating centers (CMP / CRIAVS / private practitioners, etc.).
Usual methods of evaluation
Usual methods of evaluation of each of the participating centers (CMP / CRIAVS / private practitioners, etc.).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MIDSA
Multidimensional Inventory of Development, Sex, and Aggression
Usual methods of evaluation
Usual methods of evaluation of each of the participating centers (CMP / CRIAVS / private practitioners, etc.).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Express written consent of the participant after receiving the study information
* Subject making contact or being taken in charge by a psychiatric service (even an addictology service or by liberal practitioners in connection with psychiatry), a CRIAVS or a care unit dedicated to the care of perpetrators of a sexual offense (AICS) ;
* For a problem of sexual violence such as sexual harassment, assault and rape of adult women (including marital rape), incest, pedophilic or hebephilic acts, sexual sadism, exhibition, voyeurism, frotteurism, use and possession of child pornography or addiction sexual.
* Affiliated to a social security scheme
Exclusion Criteria
* Poor understanding of the French language;
* Patient imprisoned, under legal protection, under guardianship or curatorship
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert COURTOIS, MD-PhD
Role: STUDY_DIRECTOR
University Hospital of TOURS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU Lille - URSAVS Lille
Lille, , France
CH LE Vinatier - Service de Psychiatrie Légale
Lyon, , France
CHU Montpellier Lapeyronie - CRIAVS Languedoc-Roussillon
Montpellier, , France
CHU Poitiers Henri Laborit - CRIAVS - CMP Espace Vienne - SMPR
Poitiers, , France
CHRU Tours - UC3P
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A02628-31
Identifier Type: REGISTRY
Identifier Source: secondary_id
DR190059
Identifier Type: OTHER
Identifier Source: secondary_id
EV-AICS (DR190059)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.